Brief: Anika Therapeutics Inc Reports Quarterly Loss Per Share Of $0.29
Nov 8 (Reuters) - Anika Therapeutics Inc ANIK.O :
* ANIKA REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
* ANIKA THERAPEUTICS INC - REVENUE IN Q3 OF 2022 WAS $40.3
MILLION, UP 2%
* ANIKA THERAPEUTICS INC - QUARTER LOSS PER SHARE OF $0.29
* ANIKA THERAPEUTICS INC - QTRLY ADJUSTED NET LOSS OF $0.05
PER
SHARE
* ANIKA THERAPEUTICS INC - QUARTER ENDING CASH WAS $87.8
MILLION
Source text for Eikon: ID:nGNX9tlYqg
Further company coverage: ANIK.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Anika Therapeutics
See all newsAnika Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Anika Therapeutics Q2 revenue rises, lifts 2026 outlook
Anika Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Anika Therapeutics Enters Fifth Amendment To Credit Agreement - SEC Filing
Anika Therapeutics Q1 revenue rises 13%